Researchers develop new drugs for treating polycystic hepatorena

These new drugs are capable of blocking the growth of hepatic and renal cysts in experimental models of polycystic hepatorenal disease. After receiveing the FIPSE national award for Innovation, the drugs were patented and licensed to a pharmaceutical company in the Basque Country for the purpose of furthering their clinical study.